Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Thermo Fisher Scientific
  6. News
  7. Summary
    TMO   US8835561023

THERMO FISHER SCIENTIFIC

(TMO)
  Report
Real-time Estimate Cboe BZX  -  05/17 03:04:25 pm EDT
555.25 USD   +2.94%
05/11TRANSCRIPT : Thermo Fisher Scientific Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2022 09:20 AM
CI
05/11IonPath, Inc. announced that it has received funding from Thermo Fisher Scientific Inc.
CI
05/10Thermo Fisher Scientific Introduces QualTrak Biopharma qPCR Solutions to Streamline Biologics Development and Compliance
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific Exec Says Pricing Is Going To Be Higher In 2022 Than In Past Years- JPM Conf

01/11/2022 | 08:54am EDT
share with twitter
share with LinkedIn
share with facebook

Jan 11 (Reuters) - Thermo Fisher Scientific Inc:

* THERMO FISHER SCIENTIFIC EXEC SAYS DEMAND FOR VACCINES WILL BE RELEVANT AT LEAST INTO 2023, HARDER TO TELL BEYOND THAT- JPM CONF

* THERMO FISHER SCIENTIFIC EXEC SAYS PRICING IS GOING TO BE HIGHER IN 2022 THAN IN PAST YEARS- JPM CONF Further company coverage:


© Reuters 2022
All news about THERMO FISHER SCIENTIFIC
05/11TRANSCRIPT : Thermo Fisher Scientific Inc. Presents at Bank of America 2022 Healthcare Con..
CI
05/11IonPath, Inc. announced that it has received funding from Thermo Fisher Scientific Inc.
CI
05/10Thermo Fisher Scientific Introduces QualTrak Biopharma qPCR Solutions to Streamline Bio..
CI
05/06THERMO FISHER SCIENTIFIC INC. Management's Discussion and Analysis of Financial Condit..
AQ
05/06Thermo Fisher Scientific to Present at BofA Securities 2022 Healthcare Conference
BU
05/06INSIDER SELL : Thermo Fisher Scientific
MT
05/05Interim report 1 January – 31 March 2022
AQ
05/04Thermo Fisher Scientific Inc. Launches Thermo Scientificdionex CR-CTC III Application W..
CI
04/29Morgan Stanley Adjusts Thermo Fisher Scientific's Price Target to $670 from $700, Keeps..
MT
04/28SECTOR UPDATE : Health Care Stocks Carried Higher in Thursday Markets Recovery
MT
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2022 42 581 M - -
Net income 2022 6 865 M - -
Net Debt 2022 25 677 M - -
P/E ratio 2022 31,2x
Yield 2022 0,22%
Capitalization 211 B 211 B -
EV / Sales 2022 5,56x
EV / Sales 2023 5,27x
Nbr of Employees 130 000
Free-Float 88,9%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Last Close Price 539,38 $
Average target price 669,21 $
Spread / Average Target 24,1%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
THERMO FISHER SCIENTIFIC-18.86%211 147
DANAHER CORPORATION-25.12%176 375
INTUITIVE SURGICAL, INC.-38.90%78 802
SIEMENS HEALTHINEERS AG-15.74%64 712
EDWARDS LIFESCIENCES CORPORATION-25.95%59 645
BOSTON SCIENTIFIC CORPORATION-6.26%56 926